Bax is essential for death receptor-mediated apoptosis in human colon cancer cells

Cancer Biother Radiopharm. 2012 Nov;27(9):577-81. doi: 10.1089/cbr.2012.1256.

Abstract

To demonstrate the role of Bax in death receptor-induced apoptosis in the human colon cancer HCT116 cells. We treated HCT116 cells and HCT116 with p53(-/-) (KO) by 0.1 μg/mL TRAIL for 24 hours, which indicated that HCT116 parental cells are sensitive to p53-independent death receptor-induced apoptosis. Although the p53 signaling pathway is totally intact in this system, the down-regulation of Bax in HCT116 cells is dramatically resistant to TRAIL and failed to undergo apoptosis. However, the over-expression of Bax can rescue the sensitivity of apoptosis induced by the death receptor. Our study has revealed an essential role for Bax in death receptor-induced apoptosis in the human colon cancer HCT116 cells. It may aid in a molecular understanding of possible defects in signal transduction and a regulation of the death receptor-induced apoptotic process.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects
  • Apoptosis / physiology*
  • Cell Culture Techniques
  • Cell Line, Tumor
  • Colonic Neoplasms / drug therapy
  • Colonic Neoplasms / genetics
  • Colonic Neoplasms / metabolism*
  • Colonic Neoplasms / pathology*
  • Gene Knockout Techniques
  • HCT116 Cells
  • Humans
  • Receptors, Death Domain / genetics
  • Receptors, Death Domain / metabolism*
  • Signal Transduction
  • TNF-Related Apoptosis-Inducing Ligand / pharmacology
  • Transfection
  • Tumor Suppressor Protein p53 / genetics
  • Tumor Suppressor Protein p53 / metabolism
  • bcl-2-Associated X Protein / genetics
  • bcl-2-Associated X Protein / metabolism*

Substances

  • BAX protein, human
  • Receptors, Death Domain
  • TNF-Related Apoptosis-Inducing Ligand
  • TP53 protein, human
  • Tumor Suppressor Protein p53
  • bcl-2-Associated X Protein